【レポートの概要（一部）】
1. Report Overview
1.1 Overview of 3D Printing for Healthcare: Industry and Market 2015-2025
1.2 3D Printing for Healthcare, Market Segmentation
1.3 Market Definition
1.4 How This Report Delivers
1.5 Main Questions Answered by This Analytical Report
1.6 Why You Should Read This Report
1.7 Methods of Research and Analysis
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to 3D Printing for the Healthcare Industry
2.1 3D Printing
2.1.1 The Original 3D Printing Process
2.1.2 Selective Laser Sintering (SLS)
2.1.3 Direct Metal Laser Sintering (DMLS)
2.1.4 Electron Beam Melting (EBM)
2.1.5 Stereolithography (SLA)
2.2 Bio-printing: The Printing of Living Cells
2.2.1 How 3D Printing With Living Tissue Works
2.2.2 The Near- and Long-Term Applications for 3D Bio-printing
2.2.3 Current Problems With 3D Bio-printing
2.3 The 3D Printing of Pharmaceuticals
2.3.1 3D Printing Technology in Drug Discovery
2.4 Classifying Medical Devices
2.4.1 The US Medical Devices Classification System
2.4.2 The EU Medical Devices Classification System
3. The 3D Printing Market for the Healthcare Industry, 2015-2025
3.1 The 3D Printing Market for Healthcare in 2013: Technology vs. Products
3.2 3D Printed Products in the Healthcare Industry: A Breakdown by Application
3.3 The 3D Printing Market for Healthcare: A Global Revenue Forecast 2015-2025
3.4 Driving and Restraining Forces Affecting That Industry
3.5 The 3D Printing Market for Healthcare: Technology vs. Products Revenue Forecast 2015-2025
3.5.1 Technology: Revenue Forecast 2015-2025
3.5.2 Drivers and Restraints in the 3D Printing Technology Submarket
3.5.3 Products: Revenue Forecast 2015-2025
3.6 The 3D Printing Market for Healthcare: Application Submarket Revenue Forecasts 2015-2025
3.6.1 Dental Products: Revenue Forecast 2015-2025
3.6.2 Medical Implants: Revenue Forecast 2015-2025
3.6.2.1 Medical Implants: Patient-Specific Orthopaedic and Cranio-maxillofacial Implants Are Produced Using 3D Printing Technology
3.6.2.2 The Driving and Restraining Factors Surrounding 3D Printed Medical Implants, 2015
3.6.3 Bio-printed Tissue: Revenue Forecast 2015-2025
3.6.4 Bio-printed Tissue: Commercial Launch in Q4 2014
3.6.5 Other Applications: Revenue Forecast 2015-2025
3.6.6 Other Applications: Medical Modelling, Prototypes and Pharmaceuticals
4. Leading National Markets for 3D Printing in Healthcare, 2015-2025
4.1 Leading National Markets – 3D Printing for Healthcare, 2013
4.2 Leading National Markets: Comparison of Revenue and Market Share, 2019 and 2025
4.3 Leading National Markets: 3D Printing for Healthcare, Grouped Revenue Forecasts, 2015-2025
4.4 The US Will Remain the Largest National Market Throughout the Forecast Period
4.4.1 Pioneering Use of 3D Printed Medical Implants in the US
4.4.2 FDA Regulatory Requirements: Abridged Pathways Encourage Innovation
4.5 The EU5 Account for 30.55% of the Market in 2013, But How Will This Change During the Forecast Period?
4.5.1 Germany Will Remain the Largest Market of the EU5 Throughout the Forecast Period
4.5.2 France: Strong Growth but a Decreasing Market Share
4.5.3 The UK: A Strong Network for 3D Printed Medical Implants Will Stimulate Sales of those Products
4.5.4 Italian Orthopaedic Device Manufacturers are Prominent Consumers of Arcam’s AM Technology
4.5.5 Spain: the Smallest Consumer in the EU5
4.6 Japan: Growth Will be Driven by Domestic and International Innovation
4.7 China: Domestic Innovation is Keeping Pace With the Western World
4.8 Will 3D Printing Penetrate the Russian Healthcare Market?
4.9 Brazil: A Rapidly Growing Dental Market Presents Opportunities for 3D Printing
4.10 The Indian Market is at an Early Stage
4.11 The RoW Market is Fast Growing
5. Market Leading Organisations in 3D Printing for Healthcare
5.1 Industry leaders in 2014
5.2 Organisations in the Medical Implants Sector
5.2.1 Stratasys: Total Revenues Up Over 80% from 2013
5.2.2 3D Systems: 574% Growth in Healthcare Revenues since 2010
5.2.3 Tissue Regeneration Systems: Commercialising 3D Printed Bioresorbable Skeletal Reconstruction Implants
5.2.4 Oxford Performance Materials: Selling Two FDA Approved Facial Reconstruction Implants
5.2.5 EOS: A Manufacturer of 3D Printers
5.2.6 Within Technologies: A Manufacturer of Software for 3D Printing
5.2.6.1 Within Medical: A New Initiative Combining Medical Implant Design Software and a 3D Printing Manufacturing Program
5.2.7 C&A Tool: Manufacturing Parts for the Surgical, Orthopaedic, Implant and Tooling Fields
5.2.8 Tronrud Engineering: A Provider of DMLS Since November 2011
5.2.9 Alphaform AG: Focussing on its 3D Printing Business
5.2.10 3T RPD Ltd: A UK-Based AM Company
5.2.11 Arcam AB Achieving Rapid Growth Since 2012
5.2.12 Xilloc Medical: Patient-Specific Implants from Design to Production
5.2.13 Renishaw: UK-based 3D Printer Manufacturer
5.2.14 Fripp Design and Research: Developed Picsima Technology for Printing Soft Tissue Prostheses
5.2.15 Materialise: A Global Software and Printing Services Provider
5.2.16 4WEB Medical: Over 3000 Spinal Implants Currently In Use
5.2.17 Replica 3dm: Offering Medical Models for the NHS
5.3 Organisations in the 3D Bio-printing Sector
5.3.1 Organovo: Offering the First 3D Bio-printed Tissue for Sale
5.3.2 RegenHU: Creating 3D Bio-printers and BioInks
5.3.3 Bio 3D Technologies: The World’s First Modular Bio-printer
5.3.4 Osteopore International: Two FDA Approved Products
5.3.5 EnvisionTEC: 3D Printing and Bio-printing Solutions
5.3.6 Rainbow Biosciences: Bio-printing Based on Magnetic Nanoparticles
5.3.7 Wake Forest Institute for Regenerative Medicine: 3D Bio-printing Research
5.3.7.1 Timeline for Commercially Available Therapeutic Applications
5.3.7.2 Commercial Applications: Drug Development
5.4 Organisations in Other Industry Sectors
5.4.1 Aprecia Pharmaceuticals: Oral Drug Delivery System Produced by 3D Printing Technology
5.4.2 The Cronin Group, University of Glasgow: Working on the 3D Printing of Pharmaceuticals
6. 3D Printing for the Healthcare Industry: The R&D Pipeline, 2014
6.1 R&D in the Field of Medical Implants
6.1.1 Improving Biocompatibility of 3D Printed Medical Implants with Vitamin B2
6.1.2 3D Printed Intervertebral Discs Could Look Forward to a Share of a $90bn Market
6.1.3 3D Printing of Bionic Organs With Enhanced Functionality
6.1.4 Returning Vision: Printing a Bionic Eye
6.2 R&D in the Field of Bioengineering
6.2.1 3D Printing of Skin Grafts: In Hospitals Within 10 Years?
6.2.2 The Production of Implantable Cartilage Using 3D Printing
6.2.3 3D Printing Blood Vessels is a Step Towards the Fabrication of Organs
6.2.3.1 Work at the University of Pennsylvania and MIT
6.2.3.2 Work at Fraunhofer
6.2.3.3 Work at Harvard
6.2.3.4 Work at The University of Iowa
6.2.4 3D Printing of Replacement Ears for Reconstructive Surgery
6.2.5 3D Printing to Fabricate Artificial Heart Valves
6.2.6 3D Printing of Nipple Areola Complex Graft for Reconstructive Surgery
6.2.7 3D Printing of Human Embryonic Stem Cells
6.3 R&D in Other Fields
6.3.1 The 3D Printing of Pharmaceuticals: The Potential to Improve Access to Pharmaceuticals in Remote Corners of the World?
6.3.2 3D Printing Pills: University of Central Lancashire
6.3.3 Bio-robots for Targeted Drug Delivery
7. Qualitative Analysis of the 3D Printing Industry for Healthcare, 2015 Onwards
7.1 3D Printing Industry for Healthcare 2014: Strengths and Weaknesses
7.1.1 Annual Growth Rate at Highest Levels To Date
7.1.2 Demand for Customised Products is High
7.1.3 3D Printed Products Can Improve Health Outcomes and Reduce Costs
7.1.4 Time and Resources Can be Saved
7.1.5 3D Printing Can Produce Complex Shapes and Parts
7.1.6 3D Printing Technology is Advancing Rapidly
7.1.7 3D Printing is Expensive
7.1.8 Economies of Scale are not Achieved Using Current Technology
7.1.9 A More Sophisticated Technology Requires Fewer Workers and New Skills
7.1.10 Access to Technology and Expertise Currently Limited
7.2 Opportunities and Threats Facing the Industry, 2015-2025
7.2.1 Governments are Funding 3D Printing R&D Projects
7.2.2 Increasing Demand for Personalised Medicine Represents a Lucrative Opportunity
7.2.3 There is Considerable Media Interest in the Technology
7.2.4 New Applications for 3D Printing Technology are Being Developed
7.2.5 Opportunities Exist in Post-Production Finishing
7.2.6 Regulatory Guidelines Must be Clarified
7.2.7 Long-term Studies of 3D Printed Medical Products Do Not Exist
7.2.8 Legal Questions Have Yet to be Answered
7.2.9 High Volume Manufacturing is More Economical Using Traditional Methods
7.3 A STEP Analysis of the 3D Printing Industry for Healthcare, 2015-2025
7.3.1 Social Influences on Market Trends
7.3.2 Technological Influences on Market Trends
7.3.3 Economic Influences on the Market
7.3.4 Political Influences on the Market
8. Research Interviews
8.1 Interview with Michael Renard, Executive Vice President, Commercial Operations, Organovo
8.1.1 On the Applications for 3D Bio-printing
8.1.2 On the Commercial Prospects of the Technology
8.1.3 On Potential Factors That Could Inhibit Development
8.1.4 On Their Newly Released exVive3D Liver Human Tissue
8.1.5 On the Future of Organovo and the 3D Bio-printing Industry
8.2 Interview with Jim Fitzsimmons, President and CEO, Tissue Regeneration Systems
8.2.1 On the Background of TRS
8.2.2 On TRS’ Product Portfolio
8.2.3 On Their Commercialisation Strategy
8.2.4 On TRS’ Future
8.3 Interview with Matthew Sherry, Managing Director, Replica 3dm
8.3.1 On the History Behind Replica 3dm
8.3.2 On Their Services and R&D Pipeline
8.3.3 On Replica 3dm’s Growth Plans
8.3.4 On the 3D Printing For Healthcare Industry
8.4 Interview with Professor Lee Cronin, Regius Chair of Chemistry, University of Glasgow
8.4.1 On the Cronin Group’s 3D Printed Technology
8.4.2 On Commercialisation Opportunities for Their Technology
8.5 Interview with Peter Leys, Executive Chairman, Materialise N.V.
8.5.1 On the Beginning of Materialise N.V.
8.5.2 On the Medical Products and Services Offered by Materialise N.V.
8.5.3 On Materialise’s Most Lucrative Products and Markets in 2015 and Beyond
8.5.4 On Regulatory Challenges Facing 3D Printing in the Healthcare Industry
8.5.5 On the Prospects of Materialise N.V. Over the Forecast Period
8.6 Interview with Andy Middleton, General Manager, EMEA (Europe, Middle East and Africa), Stratasys
8.6.1 On Stratasys’ Offerings for the Healthcare Industry
8.6.2 On the Demand for 3D Printing in Healthcare
8.6.3 On the Future of 3D Printing in the Healthcare Industry
8.7 Interview with Dr Lothar Koch, Head of Biofabrication Group in the Nanotechnology Department, Laser Zentrum Hannover
8.7.1 On Laser-Assisted Bio-printing
8.7.2 On the Uses of 3D Printed Tissue
8.7.3 On 3D Printed Tissue vs. Traditional In Vitro Models
8.7.4 On 3D Printed Tissue for Transplantation
8.7.5 On Research in the Field
8.7.6 On the Timeline for Commercial Availability
9. Conclusions from Our Study
9.1 The 3D Printing Market for the Healthcare Industry: Technology vs. End Products, 2015-2025
9.2 3D Printed Products for the Healthcare Industry by Application: Comparison of Revenue, 2013, 2019 and 2025
9.3 The Leading National Markets for 3D Printing in the Healthcare Industry, 2015-2025
9.4 Trends in the Industry and Market
9.4.1 Governments Want To Be Leaders in the Field
9.4.2 Personalised Medical Products Are Penetrating The Market
9.4.3 3D Printing Technology is Already Established in the Field of Dentistry
9.4.4 Bio-printing Will Take-Off Over The Next 10 years
9.4.5 Submarkets Will Expand – Systems, Software, Raw Materials & Products
【レポート販売概要】
■ タイトル：医療産業における3Dプリンティングの世界市場■ 英文：3D Printing for Healthcare: R&D, Industry and Market 2015-2025
■ 発行日：2015年1月
■ 調査会社：visiongain
■ 商品コード：VGAIN5020409
■ 調査対象地域：世界
- インターベンション心臓病学の世界市場2017-2021：冠動脈ステント、PTCAバルーンカテーテル、インターベンションガイドワイヤ、インターベンション心臓画像システム、左心耳（LAA）閉鎖装置、アテレクトミー装置About Interventional Cardiology Interventional cardiology devices are primarily related to heart disease, and most of the heart diseases have some serious medical conditions, such as angina, congestive heart failure, and arrhythmias. These are often caused by partially blocked coronary arteries, which is the most common cause of death globally. Since the 1980s, balloon angioplasty has been the sta …
- 乾癬治療薬の世界市場予測2016-2026Psoriasis Drugs – Your Guide to R&D, Opportunities and Potential Revenues What does the future hold for treating psoriasis? Visiongain’s new report gives you multilevel revenue forecasts from 2016, helping you stay ahead in data. There you see financial results, R&D trends, opportunities and potential revenues. In our study you examine predicted sales to 2026 at overall world market, submarket, pr …
- ポイントオブケア (POC）診断の世界市場2019-2023About this market The growing geriatric population will drive the point of care (POC) diagnostics market growth in the forthcoming years. As the immune system deteriorates with age, the prevalence of diseases such as lung disease, cancer, and stroke are high among the aging population. Due to their low immunity and metabolism, the elderly requires diagnostic testing regularly. This will lead to an …
- 圧電素子の世界市場予測（～2022）：材料別、製品別（アクチュエータ、変換器、モーター、センサー、発電機）、用途別MarketsandMarkets forecasts the global piezoelectric device market to grow from USD 23.54 Billion in 2016 to USD 31.33 Billion by 2022, at a CAGR of 4.88% between 2016 and 2022. The increasing application areas for piezocomposite materials in industries and emerging energy harvesting techniques using nonconventional energy sources such as body and facial movements are creating a huge demand for th …
- グローバルにおける自動車ブレーキ・システム市場（2014-2018）About Automotive Brake Systems The brake system is an important safety component used in a vehicle to reduce the speed and assist with control of the vehicle. Brakes are evolved from the simple wooden-block brakes to the modern-day disc and drum brakes with electronic assistance. Friction brakes are used in automobiles and these brakes operate by applying friction. The ultimate goal that automotiv …
- PharmaSphere: Global Generics Strategy – Key Drivers, Markets and Trends in 2013PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013 Summary GlobalData’s "PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013" report, provides strategic analysis of the global generics industry. It discusses key trends, significant M&A deals in 2012, and describes the operations strategy of these companies. Furthermore, it includes a geogr …
- 世界のソーシャルTV市場動向（2012-2016）TechNavio's analysts forecast the Global Social TV market to grow at a CAGR of 39.6 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased adoption of social media. The Global Social TV market has also been witnessing the growth in the Gamification market. However, the difficulty in validating underlying benefits of social TV could pose a chal …
- 世界のインタラクティブ・ホワイトボード（電子黒板）市場（2014-2018）About Interactive Whiteboards An IWB is an interactive display system that projects images stored in a computer and allows users to control screen activities using a pen, stylus, or finger. The IWB was introduced to facilitate the teachers in the classrooms for delivering the content. The growing popularity and the efforts from the vendors have also helped in its penetration in the Corporate and G …
- 世界のフィトステロール市場2015The Global Phytosterols Industry Report 2015 is a professional and in-depth study on the current state of the Phytosterols industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Phytosterols market analysis is provided for the international markets including development trends, competitive landscape analy …
- 太陽電池におけるナノピラー：Nanopillars Making Solar Cells More EfficientAn effort by humans to harness the abundant source of solar energy available around us has manifested in the form solar energy being converted to many applications as diverse as heat channelizing, electricity conversion, electro mechanical applications and many more as these. The dream of solar energy for human applications was realized in the early part of this century by the invention of solar c …
- Linn Energy, LLC社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Linn Energy, LLC Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Linn Energy, LLC (Linn Energy) is an independent upstream oil and gas company. The company undertakes development and acquisition of oil, natural gas liquids (NGL’s) and gas properties across the US. Linn Energy’s operations are geographically spread across the US in the following regions, namely, …
- 世界のHadoop市場動向（2014-2018）TechNavio's analysts forecast the Global Hadoop market to grow at a CAGR of 42.04 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing generation of structured and unstructured data. The Global Hadoop market has also been witnessing the increasing consideration for NoSQL by developers. However, the lack of skilled professionals could pose a …
- スポーツツーリズムの世界市場2019-2023About this market Increasing number of fan zone to emerge as major trend in the market. The stakeholders of the sports industry are focusing on attaining a wider audience to showcase tournaments and expand their reach. This is benefiting the sports tourism industry. An increasing number of sports tournaments are focusing on establishing official fan zones. These fan areas can be established in the …
- ヘルスケア衛星接続の世界市場動向分析：コンポーネント別（医療機器、ソフトウェア、サービス）、接続性別（移動衛星、固定衛星）、エンドユーザー別、用途別、セグメント予測、2014-2025The global healthcare satellite connectivity market is expected to reach USD 10.1 billion by 2025 according to a new report by Grand View Research, Inc. Globally, rising adoption of eHealth & other services and growing usage of technology platforms by hospitals & medical providers are crucial factors that boost the market growth.Several governments are working toward providing improved basic medic …
- 法執行機関向けソフトウェアの世界市場予測（～2023年）The global law enforcement software market size to grow at a CAGR of 9.3% during the forecast period.MarketsandMarkets expects the law enforcement software market size to grow from USD 11.64 billion in 2018 to USD 18.13 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period. Major growth factors for the market include an increasing focus on community-oriented p …
